Chantal Dolan

2.5k total citations · 2 hit papers
38 papers, 1.9k citations indexed

About

Chantal Dolan is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chantal Dolan has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Ophthalmology, 18 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chantal Dolan's work include Retinal Diseases and Treatments (20 papers), Retinal Imaging and Analysis (18 papers) and Retinal and Optic Conditions (12 papers). Chantal Dolan is often cited by papers focused on Retinal Diseases and Treatments (20 papers), Retinal Imaging and Analysis (18 papers) and Retinal and Optic Conditions (12 papers). Chantal Dolan collaborates with scholars based in United States, United Kingdom and France. Chantal Dolan's co-authors include Neil M. Bressler, Rohit Varma, Jennifer Fine, Shoshana Colman, James Ward, Iván J. Suñer, Quan V. Doan, Mark D. Danese, Adam Turpcu and Beiyao Zheng and has published in prestigious journals such as The Lancet, PLoS ONE and American Journal of Public Health.

In The Last Decade

Chantal Dolan

38 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of and Risk Factors for Diabetic Macular Edema in the United States

2014 298 citations Rohit Varma, Neil M. Bressler et al. JAMA Ophthalmology profile →
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

2021 127 citations John A. Spertus, Jennifer Fine et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chantal Dolan United States	21	1.1k	882	385	327	276	38	1.9k
C Alex Harper Australia	26	1.7k 1.5×	1.2k 1.3×	113 0.3×	51 0.2×	254 0.9×	68	2.4k
Sophie Rogers Australia	23	2.4k 2.2×	1.7k 1.9×	110 0.3×	95 0.3×	190 0.7×	52	3.0k
J J Wang Australia	21	990 0.9×	942 1.1×	42 0.1×	55 0.2×	179 0.6×	28	1.4k
David Maberley Canada	29	1.9k 1.7×	1.4k 1.6×	60 0.2×	79 0.2×	246 0.9×	100	2.6k
Jin Ma China	14	369 0.3×	295 0.3×	75 0.2×	39 0.1×	137 0.5×	86	786
Brian L. VanderBeek United States	23	1.4k 1.2×	970 1.1×	52 0.1×	51 0.2×	131 0.5×	90	1.9k
Nidhi Talwar United States	21	927 0.8×	500 0.6×	78 0.2×	19 0.1×	104 0.4×	32	1.2k
Sudha Cugati Australia	19	1.3k 1.2×	798 0.9×	33 0.1×	106 0.3×	273 1.0×	36	1.6k
Taylor Blachley United States	17	884 0.8×	550 0.6×	18 0.0×	45 0.1×	115 0.4×	58	1.3k
James L. Kinyoun United States	23	1.3k 1.2×	932 1.1×	133 0.3×	58 0.2×	188 0.7×	35	2.0k

Countries citing papers authored by Chantal Dolan

Since Specialization

Citations

This map shows the geographic impact of Chantal Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chantal Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chantal Dolan more than expected).

Fields of papers citing papers by Chantal Dolan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chantal Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chantal Dolan. The network helps show where Chantal Dolan may publish in the future.

Co-authorship network of co-authors of Chantal Dolan

This figure shows the co-authorship network connecting the top 25 collaborators of Chantal Dolan. A scholar is included among the top collaborators of Chantal Dolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chantal Dolan. Chantal Dolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reaney, Matthew, et al.. (2022). Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial. PharmacoEconomics - Open. 6(4). 575–586. 2 indexed citations

Nassif, Michael E., Jennifer Fine, Chantal Dolan, et al.. (2022). Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic Cardiomyopathy. JACC Heart Failure. 10(8). 531–539. 39 indexed citations

Varma, Rohit, Neil M. Bressler, Quan V. Doan, et al.. (2020). <p>Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema</p>. Clinical ophthalmology. Volume 14. 1249–1259. 1 indexed citations

Bergen, Elsje van, et al.. (2017). Unravelling the link between reading ability and print exposure. Behavior Genetics. 47. 672–672. 1 indexed citations

Nussbaum, Nathan C., Daniel J. George, Amy P. Abernethy, et al.. (2016). Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science. Prostate Cancer and Prostatic Diseases. 19(2). 111–121. 56 indexed citations

Varma, Rohit, Neil M. Bressler, Quan V. Doan, et al.. (2015). Visual Impairment and Blindness Avoided with Ranibizumab in Hispanic and Non-Hispanic Whites with Diabetic Macular Edema in the United States. Ophthalmology. 122(5). 982–989. 22 indexed citations

Kimel, Miriam, Neil M. Bressler, Rohit Varma, et al.. (2015). Sensitivity of Functional Reading Independence (FRI) index to change in size of Geographic Atrophy. Value in Health. 18(3). A184–A184. 2 indexed citations

Bressler, Neil M., Rohit Varma, Iván J. Suñer, et al.. (2014). Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema. Ophthalmology. 121(12). 2461–2472. 48 indexed citations

Suñer, Iván J., Neil M. Bressler, Rohit Varma, et al.. (2013). Reading Speed Improvements in Retinal Vein Occlusion After Ranibizumab Treatment. JAMA Ophthalmology. 131(7). 851–851. 26 indexed citations

10.

Varma, Rohit, Neil M. Bressler, Iván J. Suñer, et al.. (2012). Improved Vision-Related Function after Ranibizumab for Macular Edema after Retinal Vein Occlusion. Ophthalmology. 119(10). 2108–2118. 126 indexed citations

11.

Bressler, Neil M., Tom Chang, Rohit Varma, et al.. (2012). Driving Ability Reported by Neovascular Age-related Macular Degeneration Patients after Treatment with Ranibizumab. Ophthalmology. 120(1). 160–168. 18 indexed citations

12.

Bressler, Neil M., Quan V. Doan, Rohit Varma, et al.. (2011). Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization. Archives of Ophthalmology. 129(6). 709–17. 93 indexed citations

13.

Varma, Rohit, Neil M. Bressler, Iván J. Suñer, et al.. (2010). Ranibizumab Improves Patient-Reported Near and Distance Vision Activities in Patients With Macular Edema Following Retinal Vein Occlusion. Investigative Ophthalmology & Visual Science. 51(13). 5212–5212. 1 indexed citations

14.

Bressler, Neil M., et al.. (2008). Self-Reported Perception of Driving Function After Ranibizumab Therapy in Patients With Neovascular Age-Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 49(13). 5578–5578. 2 indexed citations

15.

Chang, Tom, et al.. (2007). Self-Reported Perception of Driving Function Following Ranibizumab Treatment in Patients With Neovascular AMD. Investigative Ophthalmology & Visual Science. 48(13). 1830–1830. 3 indexed citations

16.

Suñer, Iván J., et al.. (2007). Vision-Related Function After Ranibizumab Treatment by Better- or Worse-Seeing Eye: 24 Month Results From MARINA. Investigative Ophthalmology & Visual Science. 48(13). 1808–1808. 3 indexed citations

17.

Schwartz, Stephen G., et al.. (2007). Patient-Reported Visual Function Over 24 Months in Predominantly Classic Neovascular AMD: Results From ANCHOR, a Phase III Trial of Ranibizumab and Verteporfin PDT. Investigative Ophthalmology & Visual Science. 48(13). 1822–1822. 3 indexed citations

18.

Bressler, Neil M., Jennifer Fine, James Ward, et al.. (2007). Relationship Between Patient-Reported Visual Function and Visual Acuity in Subjects With Neovascular AMD. Investigative Ophthalmology & Visual Science. 48(13). 1174–1174. 2 indexed citations

19.

Tennis, Patricia, Beth Sherrill, Carlos Fernández‐Peña, & Chantal Dolan. (2005). Cancer risk in asthmatic populations. Annals of Allergy Asthma & Immunology. 95(4). 354–360. 6 indexed citations

20.

Dolan, Chantal, Eugene R. Bleecker, Larry Borish, et al.. (2004). Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Annals of Allergy Asthma & Immunology. 92(1). 32–39. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact